David B. Klein
David Benshoof Klein is CEO and Co-founder of Click Therapeutics, a leading innovator in the development of prescription digital therapeutics. He is also guest faculty at the Biotechnology Program at Columbia University, NYU’s Stern School of Business, and the Columbia Business School. He was Managing Director at Opus Point Partners, which created, financed, and operated more than 10 science companies, and Senior Consultant at Pfizer, and a strategic advisor for several publicly traded and privately held life science companies.
-
MedCity Influencers, BioPharma
In Therapeutic Innovation, Digital Must Be Held to the Same Rigor as Biotech
The challenge of introducing a novel therapy is nothing new. It has been done again and again, but always from a foundation of compelling evidence…gathered through a rigorous scientific approach that demonstrates quality, safety, efficacy, and a favorable balance of benefits and risks.
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
